GH Research PLC (GHRS) Financials
GHRS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 226.3 million | 6.7 million |
| 2023-09-30 | 232.6 million | 6.8 million |
| 2023-06-30 | 240.3 million | 7.3 million |
| 2023-03-31 | 249.3 million | 7.4 million |
GHRS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -8.1 million | 642000 |
| 2023-09-30 | -10.3 million | 647000 |
| 2023-06-30 | -8.1 million | 451000 |
| 2023-03-31 | -6.9 million | 551000 |
GHRS Net Income
No data available :(
GHRS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 161.6 million | - | 974000 |
| 2023-09-30 | 161.3 million | - | 921000 |
| 2023-06-30 | 165.4 million | - | 999000 |
| 2023-03-31 | 162.8 million | - | 1.1 million |
GHRS Shares Outstanding
GHRS Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 24000 | 8.3 million | 2.8 million | 71000 |
| 2023-09-30 | 8000 | 7.1 million | 2.6 million | - |
| 2023-06-30 | 46000 | 7.2 million | 2.7 million | - |
| 2023-03-31 | 22000 | 7.3 million | 3.0 million | - |
GHRS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | - | 78000 |
| 2023-09-30 | - | 80000 |
| 2023-06-30 | - | 80000 |
| 2023-03-31 | - | 77000 |
GHRS
Price: $11.68
52 week price:
Earnings Per Share: -0.68 USD
P/E Ratio: -10.13
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 6316
Market Capitalization: 582.2 million